¼¼°èÀÇ ¹ß¹é¼±(¹«Á») Ä¡·á ½ÃÀå
Tinea Pedis (Athlete¢¥s Foot) Treatment
»óǰÄÚµå : 1513909
¸®¼­Ä¡»ç : Global Industry Analysts, Inc.
¹ßÇàÀÏ : 2024³â 07¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 284 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 5,850 £Ü 8,301,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 17,550 £Ü 24,905,000
PDF (Global License to Company and its Fully-owned Subsidiaries) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


Çѱ۸ñÂ÷

¹ß¹é¼±(¹«Á») Ä¡·á ¼¼°è ½ÃÀåÀº 2030³â±îÁö 13¾ï ´Þ·¯¿¡ ´ÞÇÒ Àü¸ÁÀÔ´Ï´Ù.

2023³â¿¡ 10¾ï ´Þ·¯·Î ÃßÁ¤µÇ´Â ¹ß¹é¼±(¹«Á») Ä¡·á ¼¼°è ½ÃÀåÀº ºÐ¼® ±â°£ 2023-2030³â¿¡ CAGR 3.1%·Î ¼ºÀåÇÏ¿© 2030³â¿¡´Â 13¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. º» º¸°í¼­¿¡¼­ ºÐ¼®ÇÑ ºÎ¹® Áß ÇϳªÀÎ ±¹¼Ò Åõ¿©´Â CAGR 3.3%·Î ¼ºÀåÀ» Áö¼ÓÇϰí, ºÐ¼® ±â°£ Á¾·á ½Ã¿¡´Â 7¾ï 5,630¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. °æ±¸ Åõ¿© ºÎ¹®ÀÇ ¼ºÀå·üÀº ºÐ¼® ±â°£ µ¿¾È CAGR 2.8%·Î ÃßÁ¤µË´Ï´Ù.

¹Ì±¹ ½ÃÀåÀº 2¾ï 7,470¸¸ ´Þ·¯·Î ÃßÁ¤, Áß±¹Àº CAGR 5.2%·Î ¼ºÀå ¿¹Ãø

¹Ì±¹ÀÇ ¹ß¹é¼±(¹«Á») Ä¡·á ½ÃÀåÀº 2023³â 2¾ï 7,470¸¸ ´Þ·¯·Î ÃßÁ¤µË´Ï´Ù. ¼¼°è 2À§ °æÁ¦´ë±¹ÀÎ Áß±¹Àº 2030³â±îÁö 2¾ï 4,840¸¸ ´Þ·¯ ±Ô¸ð¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµÇ¸ç, ºÐ¼® ±â°£ 2023-2030³âÀÇ CAGRÀº 5.2%ÀÔ´Ï´Ù. ±âŸ ÁÖ¸ñÇÒ ¸¸ÇÑ Áö¿ªº° ½ÃÀåÀ¸·Î´Â ÀϺ»°ú ij³ª´Ù°¡ ÀÖÀ¸¸ç, ºÐ¼® ±â°£ Áß CAGRÀº °¢°¢ 1.7%¿Í 2.6%·Î ¿¹ÃøµÇ°í ÀÖ½À´Ï´Ù. À¯·´¿¡¼­´Â µ¶ÀÏÀÌ CAGR 2.1%·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

¹ß¹é¼±(¹«Á») Ä¡·á - ÁÖ¿ä µ¿Çâ°ú ÃËÁø¿äÀÎ

¹ß¹é¼±(¹«Á»)Àº ÀϹÝÀûÀÎ °õÆÎÀÌ °¨¿°ÀÌ¸ç Æ¯È÷ µû¶æÇÏ°í ½ÀÇÑ È¯°æ¿¡¼­ ¹ß ÇǺθ¦ ħ¹üÇÕ´Ï´Ù. ÀÌ °¨¿°Àº ±×·¯ÇÑ È¯°æ¿¡¼­ ¹ø½ÄÇÏ´Â °õÆÎÀÌ ÀÎ ÇǺΠ»ç»ó±Õ¿¡ ÀÇÇØ À¯¹ßµÇ¸ç ¹ß°¡¶ô »çÀÌ¿Í ¹ß¹Ù´ÚÀÇ °¡·Á¿ò, È«Á¶, ±Õ¿­ µîÀÇ Áõ»óÀ» À¯¹ßÇÕ´Ï´Ù. °æ¿ì¿¡ µû¶ó ¹°ÁýÀÌ »ý±â°Å³ª ²®ÁúÀÌ ¹þ°ÜÁú ¼ö ÀÖ½À´Ï´Ù. ¹«Á»Àº °¨¿°¼ºÀÌ °­ÇÏ°í °¨¿°ÀÚ¿ÍÀÇ Á÷Á¢ÀûÀÎ Á¢ÃËÀ̳ª ·ÎÄ¿·ë ¹Ù´Ú, »þ¿ö, ¼ö¿µÀå Áö¿ª µîÀÇ ¿À¿°µÈ Ç¥¸éÀ» ¸¸Áö¸é °¨¿°ÀÌ ÆÛÁý´Ï´Ù. Ä¡·á¿¡´Â ÀϹÝÀûÀ¸·Î Ç×Áø±ÕÁ¦°¡ »ç¿ëµÇ¸ç °¨¿°ÀÇ ÁßÁõµµ¿¡ µû¶ó ¿Ü¿ë ¶Ç´Â ³»º¹µË´Ï´Ù. °æÁõÀÇ °æ¿ì¿¡´Â ½ÃÆÇµÇ´Â Ç×Áø±Õ Å©¸², ÆÄ¿ì´õ, ½ºÇÁ·¹À̰¡ ÀϹÝÀûÀ¸·Î »ç¿ëµÇÁö¸¸ ½É°¢ÇÑ °æ¿ì³ª °¨¿°ÀÌ Áö¼ÓµÇ´Â °æ¿ì¿¡´Â ó¹æÀüÀÌ ÇÊ¿äÇÒ ¼ö ÀÖ½À´Ï´Ù.

¹ß¹é¼± Ä¡·áÀÇ Áøº¸·Î ´Ù¾çÇÑ È¿°úÀûÀÎ ¿É¼ÇÀÌ ÀÖ½À´Ï´Ù. Ŭ·ÎÆ®¸®¸¶Á¹, ¹ÌÄÚ³ªÁ¹, Å׸£ºñ³ªÇɰú °°Àº ±¹¼Ò Ç×Áø±Õ Ä¡·á´Â ³Î¸® ÀÌ¿ë °¡´ÉÇÏ¸ç ¸¹Àº ȯÀÚ¿¡°Ô È¿°úÀûÀÔ´Ï´Ù. ÀÌ·¯ÇÑ Ä¡·á´Â °õÆÎÀÌÀÇ ¼¼Æ÷¸·À» ÆÄ±«ÇÏ¿© °õÆÎÀ̸¦ Á×ÀÌ°í ´õ ÀÌ»óÀÇ Áõ½ÄÀ» ¹æÁöÇÕ´Ï´Ù. º¸´Ù ½ÉÇÑ °¨¿°À̳ª ±¤¹üÀ§ÇÑ °¨¿°¿¡´Â Ç÷çÄÚ³ªÁ¹À̳ª ÀÌÆ®¶óÄÚ³ªÁ¹ µîÀÇ °æ±¸ Ç×Áø±ÕÁ¦°¡ ó¹æµÇ´Â °æ¿ì°¡ ¸¹½À´Ï´Ù. ÀÌ Àü½Å Ä¡·á´Â ¿Ü¿ë ¿ä¹ý¸¸À¸·Î´Â È¿°ú°¡¾ø´Â ȯÀÚ¿¡°Ô ƯÈ÷ È¿°úÀûÀÔ´Ï´Ù. ¶ÇÇÑ Ç×Áø±ÕÁ¦¿Í Ç׿°Áõ ¼ººÐÀ» Æ÷ÇÔÇÑ º´¿ë ¿ä¹ýÀÌ °³¹ßµÈ °ÍÀ¸·Î °¨¿°°ú °¡·Á¿òÁõÀ̳ª ¿°Áõ µîÀÇ °ü·Ã Áõ»ó ¸ðµÎ¿¡ ´ëóÇÒ ¼ö ÀÖ°Ô µÇ¾î Ä¡·á ¼ºÀûÀÌ Çâ»óµÇ°í ÀÖ½À´Ï´Ù. ´Ù¸®¸¦ °ÇÁ¶½Ã۰í Åë±â¼ºÀÌ ÁÁÀº ½Å¹ßÀ» ½Å°í ¸öÀÇ ÁÖÀ§ÀÇ °ÍÀ» °øÀ¯ÇÏÁö ¾Ê´Â µîÀÇ ¿¹¹æÃ¥µµ, ¹«Á»ÀÇ °ü¸® ¹× ¿¹¹æ¿¡´Â Áß¿äÇÕ´Ï´Ù.

¹ß¹é¼± Ä¡·á ½ÃÀåÀÇ ¼ºÀåÀº ¿©·¯ ¿äÀο¡ ÀÇÇØ ÃÊ·¡µË´Ï´Ù. °õÆÎÀÌ °¨¿°°ú °Ç°­¿¡ ¹ÌÄ¡´Â ¿µÇâ¿¡ ´ëÇÑ ÀνÄÀÌ ³ô¾ÆÁü¿¡ µû¶ó È¿°úÀûÀÎ Ä¡·á¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. µå·¡±× Á¦Çü ¹× ¾à¹°Àü´Þ ½Ã½ºÅÛÀÇ ±â¼úÀû Áøº¸´Â º¸´Ù È¿À²ÀûÀÌ°í Æí¸®ÇÑ Ä¡·á ¿É¼ÇÀ» Á¦°øÇÏ¿© ȯÀÚÀÇ ÄÄÇöóÀÌ¾ð½º¿Í Ä¡·á ¼ºÀûÀ» Çâ»ó½ÃÄ×½À´Ï´Ù. ¶Ç, ½ºÆ÷Ã÷³ª ¿Á¿Ü Ȱµ¿¿¡ÀÇ Âü°¡ Áõ°¡ µî, ¹«Á»ÀÇ ¸¸¿¬À» Á¶ÀåÇÏ´Â »ýȰ ½À°ü ¿äÀÎÀÇ À¯Ç൵ ½ÃÀå ÁøÃâ±â¾÷ÀÇ ¼ºÀåÀ» µÞ¹ÞħÇϰí ÀÖ½À´Ï´Ù. °Ô´Ù°¡, ÀÇ·á ÀÎÇÁ¶ó°¡ È®´ëµÇ°í, ½ÃÆÇ¾àÀ» ÀÌ¿ëÇÒ ¼ö ÀÖ°Ô µÊÀ¸·Î½á, º¸´Ù ¸¹Àº »ç¶÷µéÀÌ Ä¡·á¸¦ ¹Þ±â ½¬¿öÁö°í ÀÖ½À´Ï´Ù. »õ·Î¿î Ç×Áø±ÕÁ¦ÀÇ °³¹ßÀ̳ª º´¿ë ¿ä¹ýÀÇ ¿¬±¸°¡ ÁøÇàµÊÀ¸·Î½á, Ä¡·áÀÇ ÆøÀÌ °è¼Ó ³Ð¾îÁö°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ ±³À° Ä·ÆäÀΰú ÇÁ·Î¸ð¼ÇÀ» Æ÷ÇÔÇÑ Á¦¾à ȸ»çÀÇ ¸¶ÄÉÆÃ Àü·«µµ ¼ÒºñÀÚ ÀÎÁöµµ¸¦ ³ôÀ̰í ÀÌ·¯ÇÑ Ä¡·á¹ýÀÇ º¸±ÞÀ» µÞ¹ÞħÇϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ µ¿ÇâÀÌ ÁøÈ­¸¦ °è¼ÓÇϰí ÀÖ´Â °¡¿îµ¥, ¹ß¹é¼± Ä¡·á ½ÃÀåÀº Áö¼ÓÀûÀÎ ±â¼ú Çõ½Å°ú °³ÀÎ À§»ý ¹× ¿¹¹æ ÀÇ·á¿¡ ´ëÇÑ °ü½ÉÀÇ ³ô¾ÆÁü¿¡ ÁöÁöÇØ Áö¼ÓÀûÀÎ ¼ºÀåÀÌ Àü¸ÁµË´Ï´Ù.

Á¶»ç ´ë»ó ±â¾÷ ¿¹(ÁÖ¸ñÀÇ 43»ç)

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå ½ÃÀå ºÐ¼®

Á¦4Àå °æÀï

JHS
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Global Tinea Pedis (Athlete's Foot) Treatment Market to Reach US$1.3 Billion by 2030

The global market for Tinea Pedis (Athlete's Foot) Treatment estimated at US$1.0 Billion in the year 2023, is expected to reach US$1.3 Billion by 2030, growing at a CAGR of 3.1% over the analysis period 2023-2030. Topical Administration, one of the segments analyzed in the report, is expected to record a 3.3% CAGR and reach US$756.3 Million by the end of the analysis period. Growth in the Oral Administration segment is estimated at 2.8% CAGR over the analysis period.

The U.S. Market is Estimated at US$274.7 Million While China is Forecast to Grow at 5.2% CAGR

The Tinea Pedis (Athlete's Foot) Treatment market in the U.S. is estimated at US$274.7 Million in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$248.4 Million by the year 2030 trailing a CAGR of 5.2% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 1.7% and 2.6% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 2.1% CAGR.

Tinea Pedis (Athlete's Foot) Treatment - Key Trends and Drivers

Tinea pedis, or athlete's foot, is a common fungal infection that affects the skin on the feet, particularly in warm and moist environments. This infection is caused by dermatophytes, fungi that thrive in such conditions, leading to symptoms like itching, burning, and cracked skin between the toes or on the soles of the feet. In some cases, the infection can cause blistering or peeling skin. Athlete's foot is highly contagious, spreading through direct contact with an infected individual or by touching contaminated surfaces, such as locker room floors, showers, and pool areas. Treatment typically involves antifungal medications, which can be applied topically or taken orally, depending on the severity of the infection. For mild cases, over-the-counter antifungal creams, powders, and sprays are commonly used, while more severe or persistent infections may require prescription-strength medications.

Advancements in the treatment of tinea pedis have led to a variety of effective options. Topical antifungal treatments like clotrimazole, miconazole, and terbinafine are widely accessible and effective for many patients. These treatments work by disrupting the cell membranes of the fungi, thereby killing them and preventing further growth. For more severe or widespread infections, oral antifungal medications such as fluconazole and itraconazole are often prescribed. These systemic treatments are particularly beneficial for patients who do not respond to topical therapies alone. Additionally, the development of combination therapies that include antifungal agents and anti-inflammatory ingredients has improved treatment outcomes by addressing both the infection and associated symptoms like itching and inflammation. Preventive measures, including keeping feet dry, wearing breathable footwear, and avoiding the sharing of personal items, are also important in managing and preventing athlete's foot.

The growth in the tinea pedis treatment market is driven by several factors. Increased awareness of fungal infections and their health impacts has led to a higher demand for effective treatments. Technological advancements in drug formulation and delivery systems have resulted in more efficient and convenient treatment options, improving patient compliance and outcomes. The rising prevalence of lifestyle factors that contribute to the spread of athlete's foot such as increased participation in sports and outdoor activities also fuels market growth. Additionally, the expansion of healthcare infrastructure and the availability of over-the-counter medications have made treatments more accessible to a wider population. The development of new antifungal agents and ongoing research into combination therapies continue to broaden the treatment landscape. Marketing strategies by pharmaceutical companies, including educational campaigns and promotions, have also heightened consumer awareness and driven the adoption of these treatments. As these trends continue to evolve, the tinea pedis treatment market is expected to see sustained growth, supported by ongoing innovations and an increasing focus on personal hygiene and preventive healthcare.

Select Competitors (Total 43 Featured) -

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

III. MARKET ANALYSIS

IV. COMPETITION

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â